Cobre_Miner Posted - 1 week ago

@docholliday22 @History101 have to agree …. It makes more sense for $BMY to step up and establish a partnership, at least, to gain a lion’s share of the schizophrenia market for the next decade. $ABBV is reeling from their mistake with $CERE …

Cobre_Miner Posted - 1 week ago

@Princessofdoom you are right $CERE was a SCAM! Poor $ABBV should had made a deal with $RVPH

betachaser Posted - 1 week ago

$VKTX ridiculous price action but not surprising given this is clinical stage biotech. Conservatively, $2 billion VK2809, $1 billion in cash, so this is being given roughly $3 billion for VK2735 which is best in class SC & Oral for Obesity. Boggles the mind how BP spent so much on garbage acquisitions like $cere and $sgen yet haven’t pounced on something as game changing as this yet.

Pika_Capital Posted - 1 week ago

$ABBV $CERE $8b down the drain lol 🤡 Should have bought $NBIX for $15-20B

Trading_Angels Posted - 2 weeks ago

Super trends BIOtechs 2025: Upstream Bio ($UPB) clinical-stage biotechnology company developing treatments for inflammatory diseases, focus on severe respiratory disorders. Its lead product, verekitug, targets the TSLP receptor, addressing a significant unmet medical need. The experienced management team and substantial financial backing position Upstream Bio favorably for future growth. Intellia Therapeutics ($NTLA) Pioneering CRISPR/Cas9-based gene-editing therapies. Outlook: promising clinical data suggest significant potential in treating genetic diseases. Cerevel Therapeutics ($CERE) Developing therapies for central nervous system disorders, including Parkinson's, epilepsy, and schizophrenia. Sufficient cash reserves, positioned for potential upside by 2025. Vertex Pharmaceuticals ($VRTX) Focus: Specializes in treatments for cystic fibrosis and is expanding into gene-editing therapies, robust pipeline and strategic collaborations.

NoRisksNoFun Posted - 2 weeks ago

$ARKG but $SNTI $CERE are deep in red!

quickaspeter Posted - 10/22/24

@TradingtooRetire @Idvst8 I believe $IOVA is little over 5% of their portfolio, while $CERE is their top holding.

anesthesia_sleep Posted - 2 months ago

$NKGN Today announced POSITIVE phase 1 Data in Alzheimer’s Disease! NKGen’s cryopreserved autologous enhanced NK cell therapy for the treatment of moderate Alzheimer’s disease Here are the billion dollar Alzheimer’s companies: $BIIB with LEQEMBI $ITCI with Intra-Cellular Therapies for treating psychosis in Alzheimer’s $CERE hallucinations and delusions associated with Alzheimer's disease psychosis

willdenton331 Posted - 08/27/24

$CERE thank you for a nice ride

SaintJeremiah Posted - 3 months ago

$ABBV $CERE $MRNA 1000% upside & undervalued pulled back to the point of a gap up or squeeze, recently received fast track for pancreatic cancer

DLBEE Posted - 3 months ago

@Nochtar Abbvie just bought $CERE for $45 a share on July 31 2024.

G101SPM Posted - 3 months ago

$ABBV $CERE $45.00. TAKE PROFIT DAC (dollar average cost) $41.90 (4.18.24) PRINT 8.1.24 AbbVie announced that it has completed its acquisition of Cerevel Therapeutics $CERE. note: In December 2023, the companies signed a definitive agreement under which AbbVie agreed to acquire Cerevel for $45 per share in cash.

BottomFishers Posted - 3 months ago

$KTTA Bears are getting forced out by EoD🔥 $VALE $CERE $SWN.DL1024 $SWIN

Stock_Titan Posted - 3 months ago

$ABBV $CERE AbbVie Completes Acquisition of Cerevel Therapeutics https://www.stocktitan.net/news/ABBV/abb-vie-completes-acquisition-of-cerevel-f0y604h738kk.html

tradingcalendar Posted - 07/31/24

Cerevel Therapeutics $CERE being acquired by AbbVie $ABBV - Shares of CERE to be delisted tonight after 8PM ET - Shareholders to receive $45.00 cash per share More information : https://www.sec.gov/Archives/edgar/data/1805387/000119312523290342/d509048ddefa14a.htm

tradethehalt Posted - 07/31/24

$CERE trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $44.97 Vol: 15.04M.

jbraun123 Posted - 07/31/24

$CERE Per DTC, expect payout to happen tmrw :) GLTA

NVDAMillionaire Posted - 07/30/24

$CERE Cerevel Therapeutics Holdings, Inc. (CERE): A Promising Neuroscience Powerhouse Poised for Transformative Growth http://beyondspx.com/2024/07/30/cerevel-therapeutics-holdings-inc-cere-a-promising-neuroscience-powerhouse-poised-for-transformative-growth/

flytrader1 Posted - 07/26/24

$CERE No news for months except for the FCC scare recently. They will release earnings shortly which most likely explains the rebound in price as the market anticipates that the deal will close in weeks.

paiocje Posted - 4 months ago

$CERE Why is pre-market on YF and stocktwits showing $44 but IBKR says no change from close?

paiocje Posted - 4 months ago

$CERE Is anyone actually active on this board? Remarkably quiet vs deals like SGEN

gentleowl Posted - 4 months ago

$CERE tomorrow 43$

TickerDD_com Posted - 4 months ago

From 6/17/2024, looking back across 21 Month-Ends for CERE, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $CERE #CERE #CEREStock #TickerDD #CEREPrice https://www.youtube.com/watch?v=VerL56oiKjI

PeedyWeedy Posted - 06/29/24

$CERE Is there an upcoming data release for darigabat, if so, when it is expected? Thanks.

KCSVEN Posted - 06/26/24

$CERE According to a Seeking Alpha article: "While there was no specific reason for the drop on Tuesday, some traders told Seeking Alpha there was some vague speculation out of unidentified broker that the FTC was gearing up for a lawsuit and that Cerevel (CERE) was increasingly looking like it may be the target for the regulator. Some people also attributed the weakness to the Russell index reconstitution on Friday and some options trades on Tuesday."

OpenOutcrier Posted - 06/25/24

RECAP 6/25 Unusual Puts: $CERE Aug 40/35 P Spd $LW Aug 75 P Live Breaking trading news www.openoutcrier.com

KCSVEN Posted - 06/25/24

$CERE FROM YAHOO BOARD Abbvie had their Parkinson’s drug turned down by the FDA today because they did not like what they found at the manufacturing plant run by a third-party unrelated company. The FDA said there are no issues at all with the actual drug and they are not making any requests for new studies or information about the drug, but yes, it could delay drug approval. people are probably worried that it will delay CERE’s drug as well, and if this would be considered a MAC that would allow abbvie to cancel the deal. Read the Delaware contract and you will see that that is not a MAC, even if they wanted out of the deal, and they do not. The contract specifies that drug approval is NOT a MAC, thus abbvie assumes all risk. This is simply people getting afraid, but they will quickly realize there’s no reason. Take advantage of it and buy some now. Even if the actual manufacturing and drug approval is delayed it has nothing to do with the timing of the buyout being finalized.

TeresaTrades Posted - 06/25/24

Heavy options volume $PTEN $ITB $BMBL $CERE $FYBR

flytrader1 Posted - 06/25/24

$CERE lots of bearish option action & implied volatility has jumped

KCSVEN Posted - 06/25/24

$CERE Not good this close to when a close should be happening to be down 5% on heavy volume with a Bearish Put Spread put on right before the move. "Could" be a bear raid but also could be a sign some negative news is coming, best to be on sidelines and see what happens.